| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |